301 related articles for article (PubMed ID: 9718213)
1. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection.
Honoré S; Garin YJ; Sulahian A; Gangneux JP; Derouin F
FEMS Immunol Med Microbiol; 1998 Jul; 21(3):231-9. PubMed ID: 9718213
[TBL] [Abstract][Full Text] [Related]
2. Leishmania infantum: mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice.
Rolão N; Cortes S; Gomes-Pereira S; Campino L
Exp Parasitol; 2007 Mar; 115(3):270-6. PubMed ID: 17087930
[TBL] [Abstract][Full Text] [Related]
3. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
Rosypal AC; Zajac AM; Troy GC; Lindsay DS
Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
[TBL] [Abstract][Full Text] [Related]
4. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
Agallou M; Margaroni M; Karagouni E
Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
[TBL] [Abstract][Full Text] [Related]
5. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
Pirdel L; Farajnia S
Scand J Immunol; 2017 Jul; 86(1):15-22. PubMed ID: 28426153
[TBL] [Abstract][Full Text] [Related]
6. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs.
Daneshvar H; Molaei MM; Afshar RM; Kamiabi H; Burchmore R; Hagan P; Phillips RS
Vet Immunol Immunopathol; 2009 May; 129(1-2):28-35. PubMed ID: 19147233
[TBL] [Abstract][Full Text] [Related]
7. Understanding Resistance vs. Susceptibility in Visceral Leishmaniasis Using Mouse Models of
Pérez-Cabezas B; Cecílio P; Gaspar TB; Gärtner F; Vasconcellos R; Cordeiro-da-Silva A
Front Cell Infect Microbiol; 2019; 9():30. PubMed ID: 30881923
[TBL] [Abstract][Full Text] [Related]
8. Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge.
Ferrua B; Luci C; Le Fichoux Y; Paul A; Marty P
Vaccine; 2006 Jan; 24(5):589-96. PubMed ID: 16157427
[TBL] [Abstract][Full Text] [Related]
9. Experimental pathogenicity of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model.
Sulahian A; Garin YJ; Pratlong F; Dedet JP; Derouin F
FEMS Immunol Med Microbiol; 1997 Mar; 17(3):131-8. PubMed ID: 9093833
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection.
Parody N; Soto M; Requena JM; Alonso C
Parasite Immunol; 2004; 26(6-7):283-93. PubMed ID: 15541032
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T
Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586
[TBL] [Abstract][Full Text] [Related]
12. Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.
Nation CS; Dondji B; Stryker GA
Parasitol Res; 2012 Sep; 111(3):1407-15. PubMed ID: 22476599
[TBL] [Abstract][Full Text] [Related]
13. T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with Leishmania infantum.
Cuervo-Escobar S; Losada-Barragán M; Umaña-Pérez A; Porrozzi R; Saboia-Vahia L; Miranda LH; Morgado FN; Menezes RC; Sánchez-Gómez M; Cuervo P
PLoS One; 2014; 9(12):e114584. PubMed ID: 25535967
[TBL] [Abstract][Full Text] [Related]
14. Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte.
Rodrigues A; Claro M; Alexandre-Pires G; Santos-Mateus D; Martins C; Valério-Bolas A; Rafael-Fernandes M; Pereira MA; Pereira da Fonseca I; Tomás AM; Santos-Gomes G
Immunobiology; 2017 Feb; 222(2):409-422. PubMed ID: 27615509
[TBL] [Abstract][Full Text] [Related]
15. Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.
Moreira Nd; Vitoriano-Souza J; Roatt BM; Vieira PM; Ker HG; de Oliveira Cardoso JM; Giunchetti RC; Carneiro CM; de Lana M; Reis AB
PLoS One; 2012; 7(10):e47907. PubMed ID: 23112869
[TBL] [Abstract][Full Text] [Related]
16. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.
Silva SC; Silva DF; Almeida TC; Perasoli FB; da Silva ATP; da Silva GN; Rezende SA
Parasitol Res; 2018 Sep; 117(9):2881-2893. PubMed ID: 29943317
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis.
Agallou M; Smirlis D; Soteriadou KP; Karagouni E
Vaccine; 2012 Jul; 30(34):5086-93. PubMed ID: 22704924
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production.
Gomes-Pereira S; Rodrigues OR; Rolão N; Almeida PD; Santos-Gomes GM
FEMS Immunol Med Microbiol; 2004 May; 41(1):59-68. PubMed ID: 15094168
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis.
Gangneux JP; Chau F; Sulahian A; Derouin F; Garin YJ
Eur Cytokine Netw; 1999 Dec; 10(4):557-9. PubMed ID: 10586123
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]